Please login to the form below

Not currently logged in
Email:
Password:

Chemia appoints network manager

Ellie Duncanson-Hunter joins from PMGroup where she was events director

edit-EllieDH-1Chemia - Creston Health's global network of specialist healthcare consultancies - has appointed Ellie Duncanson-Hunter as network manager.

She will manage the day-to-day running of the network and report to the Chemia leadership team, made up of Tim Bird from Cooney/Waters Group, PAN's Eric Hansen and Andrew Thomas from Red Door Communications.

Duncanson-Hunter said of her appointment: “I am thrilled to be taking up this inaugural role and look forward to the challenge of optimising network operations and developing Chemia's global business.”

She joins from PMGroup where she was events director, with responsibility for the Communiqué Awards, PMEAs and Quality in Care programmes after being promoted from the role of awards and marketing manager. Previous to this, she worked at AstraZeneca where she managed events for the primary and specialist care brand teams.

Catherine Warne, CEO of Creston Health, said: “I am delighted to welcome Ellie to the Creston Health family. I have worked with Ellie on Communiqué for the past three years so know she is going to be a great asset to the team.”

Chemia is an integrated network of agencies offering a range of marketing services including public relations, advertising, brand ideation, planning, medical education, digital and social media.

2nd October 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics